Perfluorocarbon supplementation and postischemic cardiac function.

[1]  A. Meneshian,et al.  Fluosol cardioplegia results in complete functional recovery: a comparison with blood cardioplegia. , 1992, The Annals of thoracic surgery.

[2]  E. Ascer,et al.  Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon. , 1992, American journal of surgery.

[3]  James W. Davis,et al.  Comparison of preload recruitable stroke work, end-systolic pressure-volume and dP/dtmax-end-diastolic volume relations as indexes of left ventricular contractile performance in patients undergoing routine cardiac catheterization. , 1992, Journal of the American College of Cardiology.

[4]  G. Buckberg,et al.  Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate. , 1991, The Journal of thoracic and cardiovascular surgery.

[5]  Jean Charles Gilbert,et al.  Determinants of left ventricular filling and of the diastolic pressure-volume relation. , 1989, Circulation research.

[6]  V. Gott,et al.  New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation. , 1988, Circulation.

[7]  G. Schmid-Schönbein,et al.  Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. , 1986, The American journal of physiology.

[8]  A. Harjula,et al.  Effects of synthetic blood and crystalloid cardioplegic solutions on coronary endothelium: an experimental scanning electron microscope study. , 1985, The Journal of surgical research.

[9]  D. Glower,et al.  Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. , 1985, Circulation.

[10]  G. Vercellotti,et al.  Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. , 1985, Science.

[11]  L. Fink,et al.  Effect of perfluorochemical blood substitutes on human neutrophil function , 1984, Transfusion.

[12]  S. Weiss,et al.  Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. , 1984, The Journal of biological chemistry.

[13]  R. Engelman,et al.  Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest. , 1982, Circulation.

[14]  F. Dunn,et al.  Borderline Hypertension and Obesity: Two Prehypertensive States with Elevated Cardiac Output , 1982, Circulation.

[15]  G. Vercellotti,et al.  Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis , 1982 .

[16]  R. Engelman,et al.  The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest. , 1979, Surgery.

[17]  G. Buckberg.  A proposed "solution" to the cardioplegic controversy. , 1979, The Journal of thoracic and cardiovascular surgery.

[18]  J. Severinghaus.  Oxyhemoglobin dissociation curve correction for temperature and pH variation in human blood. , 1958, Journal of applied physiology.

[19]  E BERGLUND,et al.  Ventricular Function: I. Starling's Law of the Heart Studied by Means of Simultaneous Right and Left Ventricular Function Curves in the Dog , 1954, Circulation.

[20]  E. Starling,et al.  On the mechanical factors which determine the output of the ventricles , 1914, The Journal of physiology.

[21]  A. Augustin,et al.  Influence of perflubron on the creation of oxygen free radical products in mesenteric artery occlusion shock. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[22]  K. Lowe.  Blood substitutes : preparation, physiology and medical applications , 1988 .